d-alpha tocopherol has been researched along with Myelodysplastic Syndromes in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 7 (77.78) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aivado, M; Aul, C; Büsche, G; Ganser, A; Germing, U; Giagounidis, AA; Grabenhorst, U; Grips, KH; Haase, S; Heinsch, M; Kreipe, HH; Lübbert, M; Rothmann, F; Schlegelberger, B; Wilkens, L; Wysk, J | 1 |
| Ganser, A; Geissler, GR; Hoelzer, D; Maurer, AB; Mentzel, U; Ottmann, OG; Seipelt, G | 1 |
| Bourantas, KL; Christou, L; Tsiara, S | 1 |
| Contzen, C; Ganser, A; Haas, R; Hoelzer, D; Kolbe, K; Maurer, A; Ottmann, OG; Reutzel, R; Schadeck-Gressel, C; Seipelt, G; Zander, C | 1 |
| Besa, EC; Kunselman, S; Nowell, PC | 1 |
| Lebwohl, M; Salasche, SJ | 1 |
| Abrahm, JL; Bartholomew, MJ; Besa, EC; Hyzinski, M; Nowell, PC | 1 |
| Bühler, E; Clemens, MR; Ehninger, G; Einsele, H; Gey, KF; Ladner, C; Renn, W; Waller, HD | 1 |
| Clemens, MR; Ehninger, G; Gey, KF; Ladner, C | 1 |
6 trial(s) available for d-alpha tocopherol and Myelodysplastic Syndromes
| Article | Year |
|---|---|
Treatment of myelodysplastic syndrome with isolated del(5q) including bands q31-q33 with a combination of all-trans-retinoic acid and tocopherol-alpha: a phase II study.
Topics: Adult; Aged; Aged, 80 and over; alpha-Tocopherol; Bone Marrow; Chromosome Banding; Chromosome Deletion; Chromosomes, Human, Pair 5; Drug Eruptions; Drug Therapy, Combination; Erythropoiesis; Follow-Up Studies; Hemoglobins; Humans; In Situ Hybridization, Fluorescence; Middle Aged; Myelodysplastic Syndromes; Quality of Life; Treatment Outcome; Tretinoin | 2005 |
Changes in erythroid progenitor cell and accessory cell compartments in patients with myelodysplastic syndromes during treatment with all-trans retinoic acid and haemopoietic growth factors.
Topics: Adult; Aged; Blood Cell Count; Combined Modality Therapy; Cytokines; Erythroid Precursor Cells; Erythropoiesis; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Cell Growth Factors; Humans; Lymphocyte Subsets; Male; Middle Aged; Monocytes; Myelodysplastic Syndromes; Recombinant Proteins; Tretinoin; Vitamin E | 1995 |
Treatment of 34 patients with myelodysplastic syndromes with 13-CIS retinoic acid.
Topics: Aged; Anemia, Refractory; Female; Humans; Isotretinoin; Leukemia, Myelomonocytic, Chronic; Male; Middle Aged; Myelodysplastic Syndromes; Survival Rate; Time Factors; Vitamin E | 1995 |
Improved multilineage response of hematopoiesis in patients with myelodysplastic syndromes to a combination therapy with all-trans-retinoic acid, granulocyte colony-stimulating factor, erythropoietin and alpha-tocopherol.
Topics: Adult; Aged; Aged, 80 and over; Blood Cell Count; Bone Marrow; Drug Therapy, Combination; Erythropoietin; Female; Granulocyte Colony-Stimulating Factor; Hematopoiesis; Humans; Male; Middle Aged; Myelodysplastic Syndromes; Tretinoin; Vitamin E | 1996 |
A pilot trial of 13-cis-retinoic acid and alpha-tocopherol with recombinant human erythropoietin in myelodysplastic syndrome patients with progressive or transfusion-dependent anemias. The Central Pennsylvania Oncology Group.
Topics: Aged; Anemia; Erythropoietin; Female; Humans; Isotretinoin; Male; Middle Aged; Myelodysplastic Syndromes; Pilot Projects; Recombinant Proteins; Treatment Outcome; Vitamin E | 1998 |
Treatment with 13-cis-retinoic acid in transfusion-dependent patients with myelodysplastic syndrome and decreased toxicity with addition of alpha-tocopherol.
Topics: Adult; Aged; Aged, 80 and over; Blood Transfusion; Bone Marrow; Drug Combinations; Drug Interactions; Female; Humans; Isotretinoin; Karyotyping; Male; Middle Aged; Myelodysplastic Syndromes; Remission Induction; Survival Analysis; Time Factors; Vitamin E | 1990 |
3 other study(ies) available for d-alpha tocopherol and Myelodysplastic Syndromes
| Article | Year |
|---|---|
Clinical pearl: vitamin E (alpha-tocopherol), 800 IU daily, may reduce retinoid toxicity.
Topics: Humans; Isotretinoin; Myelodysplastic Syndromes; Vitamin E | 1999 |
Plasma vitamin E and beta-carotene concentrations during radiochemotherapy preceding bone marrow transplantation.
Topics: Adolescent; Adult; Anemia, Aplastic; beta Carotene; Bone Marrow Transplantation; Carotenoids; Cholesterol; Combined Modality Therapy; Erythrocyte Membrane; Female; Humans; Leukemia; Male; Myelodysplastic Syndromes; Neuroblastoma; Vitamin E | 1990 |
Effect of etoposide (VP16-213) on lipid peroxidation and antioxidant status in a high-dose radiochemotherapy regimen.
Topics: Anemia, Aplastic; Antioxidants; beta Carotene; Bone Marrow Transplantation; Carotenoids; Combined Modality Therapy; Etoposide; Humans; Leukemia; Lipid Peroxidation; Lipid Peroxides; Myelodysplastic Syndromes; Parenteral Nutrition; Radiotherapy Dosage; Time Factors; Vitamin E | 1989 |